Delivery Order SPE2DB20D2001-SPE2DB24FM55X
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,262,033 units of Bupropion HCL XL 150 mg tablets. The $10,933.71 contract has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver a wide...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The delivery order, valued at $12,723.06, is for the supply of 4,564,083,598 units of Bupropion HCL XL 150 mg tablets to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order falls under a larger indefinite delivery contract (IDC) awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,327,251 units of Bupropion HCL XL 150 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $22,514.56 and an ultimate completion date of April 19, 2024. There was no set-aside used for this award. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of 4,563,818,934 bupropion HCl XL 150 mg tablets in 500-count packages, with a potential value of $4,057.34. The contract does not have a set-aside designation and has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,042,870 units of Bupropion HCL XL 300 mg tablets. The order, valued at $39,859.71, has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Bupropion HCL XL 150 mg tablets. The order has a total potential value of $1,257.50 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,598.98 firm fixed price delivery order is for the supply of 4,563,970,057 units of the prescription medication Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,928 bupropion HCL XL 300 mg tablets in 500-count bottles. The $2,160 contract has an ultimate completion date of April 12, 2024 and is not set aside for any specific business type. Amerisourcebergen Drug Corp, the prime contractor, is the sole awardee on this delivery order, which is issued against a...
The U.S. government awarded a $18,459.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,247,360 units of Bupropion HCL XL 300 mg tablets. The contract, with a completion date of April 12, 2024, was issued by the Defense Logistics Agency (DLA) Troop Support Medical under an existing indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...